These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26158353)

  • 21. Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(43):1487-92. PubMed ID: 22048730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.
    Seth P; Scholl L; Rudd RA; Bacon S
    MMWR Morb Mortal Wkly Rep; 2018 Mar; 67(12):349-358. PubMed ID: 29596405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial and Ethnic Differences in Heroin, Methamphetamine, and Cocaine Use, Treatment, and Mortality Trends in 3 National Data Sources-United States, 2010-2019.
    Shearer RD; Segel JE; Howell BA; Jones AA; Khatri UG; Teixeira da Silva D; Vest N; Winkelman TNA
    Med Care; 2024 Mar; 62(3):151-160. PubMed ID: 38180005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.
    Rudd RA; Seth P; David F; Scholl L
    MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(50-51):1445-1452. PubMed ID: 28033313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription painkiller misuse and the perceived risk of harm from using heroin.
    Kapadia SN; Bao Y
    Addict Behav; 2019 Jun; 93():141-145. PubMed ID: 30711666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing characteristics of prescription painkiller misusers and heroin users in the United States.
    Rigg KK; Monnat SM
    Addict Behav; 2015 Dec; 51():106-12. PubMed ID: 26253938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.
    Guy GP; Haegerich TM; Evans ME; Losby JL; Young R; Jones CM
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(31):679-686. PubMed ID: 31393863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations.
    Unick GJ; Ciccarone D
    Int J Drug Policy; 2017 Aug; 46():112-119. PubMed ID: 28688539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic.
    Cerdá M; Ransome Y; Keyes KM; Koenen KC; Tracy M; Tardiff KJ; Vlahov D; Galea S
    Drug Alcohol Depend; 2013 Sep; 132(1-2):53-62. PubMed ID: 23357743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in Medicare beneficiaries.
    Kuo YF; Baillargeon J; Raji MA
    J Subst Abuse Treat; 2021 May; 124():108282. PubMed ID: 33771281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of adults reporting illicitly manufactured fentanyl or heroin use or prescription opioid misuse in the United States, 2019.
    Jiang X; Guy GP; Dunphy C; Pickens CM; Jones CM
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109160. PubMed ID: 34740067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: A latent class analysis.
    Schneider KE; Park JN; Allen ST; Weir BW; Sherman SG
    Drug Alcohol Depend; 2019 Aug; 201():71-77. PubMed ID: 31195347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.
    Jayawardhana J; Abraham AJ; Perri M
    J Manag Care Spec Pharm; 2018 Sep; 24(9):886-894. PubMed ID: 30156455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.
    Scholl L; Seth P; Kariisa M; Wilson N; Baldwin G
    MMWR Morb Mortal Wkly Rep; 2018 Jan; 67(5152):1419-1427. PubMed ID: 30605448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017.
    Kariisa M; Scholl L; Wilson N; Seth P; Hoots B
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):388-395. PubMed ID: 31048676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sexual minority disparities in opioid misuse, perceived heroin risk and heroin access among a national sample of US adults.
    Schuler MS; Dick AW; Stein BD
    Drug Alcohol Depend; 2019 Aug; 201():78-84. PubMed ID: 31200278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids.
    Roxburgh A; Hall WD; Gisev N; Degenhardt L
    Drug Alcohol Depend; 2019 Dec; 205():107533. PubMed ID: 31704378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Urine Drug Test Results From Substance Use Disorder Treatment Practices and Overdose Mortality Rates, 2013-2020.
    Whitley P; LaRue L; Fernandez SA; Passik SD; Dawson E; Jackson RD
    JAMA Netw Open; 2022 Jun; 5(6):e2215425. PubMed ID: 35657623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years.
    Cicero TJ; Ellis MS; Surratt HL; Kurtz SP
    JAMA Psychiatry; 2014 Jul; 71(7):821-6. PubMed ID: 24871348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.